Affymetrix to develop.

Yong Yong Shi, who run the largest genotyping laboratory in China, needed more focused, Chinese-specific content to give them better genetic coverage and even more power thus. The Chinese myDesign Genotyping Array meets these wants. The array is certainly in development and will be commercialized afterwards this year for other researchers thinking about leveraging this powerful research tool. Affymetrix customers are in the forefront in an ever-changing field of genotyping research, in fact it is our objective to continue offering the genetic data and microarray technology which will maintain them at the cutting edge of human disease research, said Affymetrix President and CEO Kevin King.Sankaran to get Rising Superstar AwardSchneider and group analyzed data collected from the Uniform Data Program for Medical Rehabilitation from 2002 to 2010 on 4572 patients in 537 inpatient rehabilitation units in america. Overall, 13 percent of transfers from the rehabilitation models were to acute care, and 2 percent of these occurred within the 1st 3 days to be admitted. Composing in the Journal of Acute and Trauma Care Surgery, the team reports that lower functional level at admission , older age , and having previously been admitted to an inpatient rehabilitation facility were all significant predictors to be transferred to acute care within 3 days.